Mechanisms of Biofilm Development and Antibiofilm Therapeutics Strategies

Dear Colleagues,

Biofilms have been found to play a key role in infections, various diseases, and implant failure. Treatment of biofilm-associated infections imposes many challenging tasks on microbiologists and clinicians. Recent decades of impressive discoveries have yielded insightful knowledge about the structure and complexity of biofilm and deepened our understanding of various aspects of biofilm pathogenesis. Microorganisms can adhere to various types of organic and abiotic surfaces, so a better understanding of the stages of biofilm formation requires an interdisciplinary approach that leads to the development of effective alternatives for prevention and control. Research and new strategies to prevent and combat biofilm are a dynamically developing branch of science. This Special Issue’s outlook is to address current biofilm-targeting strategies and those under development with a special focus on new molecules and technologies with antibiofilm capabilities. It will expand and systematize the knowledge regarding the dynamic of biofilm formation and summarize ongoing efforts related to the development and understanding of the main concerns in fungal and bacterial biofilms.

Dr. Ruth Dudek-Wicher
Dr. Joanna Żur
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Dr. Ruth Dudek-Wicher
Dr. Joanna Żur
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• biofilm
• polymicrobial biofilms
• biofilm development
• biofilm eradication
• antibiofilm activity
• targeted anti-biofilm therapy
• EPS
• quorum sensing
• metabolic
• AMP
• biofilm penetration
• enhanced antimicrobial therapy
• multi-immunotherapy